Share This Page
Suppliers and packagers for INFUVITE ADULT
✉ Email this page to a colleague
INFUVITE ADULT
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
Suppliers for the Pharmaceutical Drug: INFUVITE ADULT
Introduction
Infuvite Adult is a specialized multivitamin formulation administered via infusion to critically ill patients requiring parenteral nutrition (PN). It delivers essential vitamins and minerals directly into the bloodstream, bypassing the gastrointestinal tract, essential for patients unable to tolerate enteral feeding. Given its critical role in clinical settings, understanding its suppliers—ranging from active pharmaceutical ingredient (API) manufacturers to finished drug product producers—is vital for stakeholders across healthcare, manufacturing, and distribution channels.
Overview of INFUVITE ADULT
INFUVITE ADULT is a commercially available TPN (Total Parenteral Nutrition) supplement that combines water-soluble vitamins and trace elements critical to metabolic functions. Its composition primarily includes vitamin B complex (B1, B2, B6, B12), vitamin C, vitamin E, and various electrolytes, formulated specifically for adult patients with compromised nutritional intake. The drug’s formulation requires strict aseptic manufacturing, quality controls, and compliance with regulatory standards in different markets.
Major Suppliers of INFUVITE ADULT
1. Pharmaceutical Manufacturers and Brand Owners
Mead Johnson Nutrition (A Johnson & Johnson Company)
- Mead Johnson, acquired by Reckitt Benckiser in 2017 and subsequently divested in 2021, historically supplied INFUVITE products, including INFUVITE Adult formulations, under different regional branding. As a key market contributor, Mead Johnson’s manufacturing facilities in the US and Europe have produced both the active components and the finished infusion products.
Fresenius Kabi
- A leading global provider of infusion therapies and clinical nutrition solutions, Fresenius Kabi manufactures and distributes INFUVITE products in several markets, especially in Europe and Asia. Their expertise in sterile manufacturing of intravenous vitamins and minerals makes them a significant supplier, supplying both active ingredients and final products.
Fresenius Kabi's Role in INFUVITE Supply Chain:
- As a prominent global supplier, Fresenius Kabi’s manufacturing facilities in Germany, Austria, and India produce INFUVITE formulations, adherent to strict EU and US cGMP standards. Their extensive global logistics network ensures wide distribution, especially in hospital settings.
Abbott Laboratories
- While Abbott predominantly focuses on broader nutritional products and parenteral nutrition solutions, their involvement in vitamin and mineral premixes for parenteral use positions them as potential secondary suppliers for INFUVITE-like products. Notably, Abbott's expertise in sterile manufacturing expands industry capacity for these formulations.
Baxter International
- Baxter manufactures infusion solutions and trace element components. Though not a primary producer of INFUVITE, their role as a supplier of components (trace elements and vitamins) that integrate into final formulations warrants mention.
2. Active Pharmaceutical Ingredient (API) Manufacturers
The critical aspect of INFUVITE Adult’s supply chain involves API producers of water-soluble vitamins and trace elements.
QualiTech
- A leader in vitamin premix manufacturing, QualiTech supplies high-quality vitamin APIs used in various parenteral formulations. Their facility in the US adheres to cGMP standards and supplies APIs compatible with INFUVITE formulations.
Celgene (BioTek Industries Inc.)
- A known producer of water-soluble vitamin APIs, Celgene supports the industry’s need for sterile, injectable-grade vitamins. Their production facilities cater to both domestic and international markets.
Sidley and Mississauga-based API producers
- Several regional pharmaceutical API producers in India and China supply vitamin B complexes, C, E, and trace elements, which are then incorporated into finished products by contract manufacturers.
Distribution Channels & Supply Chain Considerations
Given the critical nature of INFUVITE Adult, its supply chain is tightly integrated, emphasizing sterile manufacturing, cold chain logistics, and compliance with international standards such as 21 CFR Part 211 (US), EU GMP, and PIC/S standards. Most suppliers operate under stringent quality Agreements, ensuring lot traceability, validation, and batch consistency.
Key distribution hubs are located in:
- North America (US, Canada)
- Europe (Germany, France, UK)
- Asia (India, China)
- Rest of the world via authorized partners
Manufacturers often rely on third-party logistics (3PL) providers specializing in pharmaceutical cold chain management to ensure product integrity across long-distance transport.
Regulatory and Patent Landscape
INFUVITE Adult's formulation and manufacturing processes are subject to regulatory oversight by agencies such as the FDA (US), EMA (Europe), and national health authorities elsewhere. Several patents around formulation, sterilization, and manufacturing processes exist, which can influence supplier options.
Trade secret protections restrict detailed public disclosure of specific manufacturing processes, but suppliers with validated cGMP-compliant manufacturing capabilities can produce equivalent formulations under licensing agreements or as authorized generics.
Market Players and Competition
The industry exhibits significant competition, with a few dominant players:
- Fresenius Kabi
- Baxter International
- Fresenius Kabi's competitors in vitamin premixes: B.Braun, Grifols
- Regional API producers: Indian pharmaceutical companies such as Synokem Pharmaceuticals, Dr. Reddy’s Laboratories, and Cipla
These players often operate under exclusive licensing, supply agreements, or OEM arrangements to meet increasing global demand.
Key Challenges and Considerations
- Supply chain disruptions: COVID-19 pandemic highlighted vulnerabilities in sourcing raw materials and sterile manufacturing capacity.
- Regulatory compliance: Ensuring API and finished product compliance across multiple jurisdictions influences supplier selection.
- Manufacturing capacity: Capacity constraints may limit availability, impacting procurement strategies.
- Intellectual Property: Patent protections on formulation or manufacturing processes could restrict market entries and influence supplier relationships.
Conclusion
The supply of INFUVITE Adult is concentrated among a handful of large, well-regulated manufacturers specializing in sterile, injectable multivitamin solutions, notably Fresenius Kabi, Baxter, and regional API suppliers. These companies operate with rigorous quality controls to meet clinical needs globally, navigating complex regulatory and logistical landscapes. Stakeholders seeking to engage as suppliers should prioritize cGMP compliance, capacity, and supply chain security to mitigate risks associated with critical parenteral nutrition products.
Key Takeaways
- Major suppliers include Fresenius Kabi, Baxter, and regional API producers, enabling the global distribution of INFUVITE Adult.
- API manufacturers of water-soluble vitamins and trace elements are essential upstream players, with US and Indian companies leading production.
- Supply chain integrity depends on strict sterile manufacturing, quality standards, and cold chain logistics.
- Regulatory compliance significantly influences supplier qualification and product approval locally and internationally.
- Market dynamics are affected by capacity constraints, patent protections, and geopolitical factors, necessitating diversified sourcing strategies.
FAQs
1. Who are the primary manufacturers of INFUVITE Adult?
Major manufacturers include Fresenius Kabi and Baxter International, with regional API suppliers providing the raw ingredients.
2. How do supply chain disruptions affect INFUVITE Adult availability?
Disruptions in raw material sourcing, manufacturing capacity, or logistics can lead to shortages, impacting patient care.
3. Are regional API producers capable of manufacturing INFUVITE components?
Yes; companies in India and China produce water-soluble vitamins and trace elements that can be incorporated into finished products under licensing agreements.
4. What regulatory standards must suppliers meet to produce INFUVITE Adult?
Suppliers must comply with cGMP standards, FDA or EMA regulations, and undergo rigorous quality audits for sterile injectable products.
5. Can smaller or new entrants supply INFUVITE Adult?
While possible, new entrants must establish validated manufacturing processes, meet regulatory requirements, and build supply chain capacity, which presents significant barriers.
References
- [1] U.S. Food and Drug Administration. cGMP for Finished Pharmaceuticals.
- [2] European Medicines Agency. Good Manufacturing Practice (GMP) guidelines for medicinal products.
- [3] Fresenius Kabi Product Portfolio and Market Reports.
- [4] Baxter International Annual Report, 2022.
- [5] Industry Reports on Injectables and Parenteral Nutrition Market, IQVIA.
More… ↓
